Search

everythinglearnresearchcommunity

for

Search:↓

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Nails can reveal important health information about skin and body conditions.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Systemic retinoids do not increase COVID-19 risk or severity.

A woman with lupus and systemic sclerosis developed severe acne that didn't improve with treatment and died from pneumonia and septic shock.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

SLE can occur in young males and cause knee pain.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Early detection and targeted management are crucial for better outcomes in systemic lupus erythematosus.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

A woman with lupus had rare severe symptoms but improved with treatment.

Fever and rash can be early signs of lupus.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Adults with certain skin conditions may have higher levels of inflammation in their body.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Animal research has greatly advanced dermatology.